Cambridge Financial Group Inc. lowered its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 5.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 23,381 shares of the healthcare conglomerate’s stock after selling 1,402 shares during the quarter. UnitedHealth Group comprises approximately 3.9% of Cambridge Financial Group Inc.’s portfolio, making the stock its 6th biggest position. Cambridge Financial Group Inc.’s holdings in UnitedHealth Group were worth $5,831,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in the business. Capital World Investors lifted its position in UnitedHealth Group by 7.2% during the fourth quarter. Capital World Investors now owns 47,932,997 shares of the healthcare conglomerate’s stock valued at $14,091,342,000 after buying an additional 3,219,554 shares during the period. State Street Corp raised its position in shares of UnitedHealth Group by 1.4% in the 4th quarter. State Street Corp now owns 45,791,556 shares of the healthcare conglomerate’s stock worth $13,461,802,000 after purchasing an additional 614,433 shares during the last quarter. Capital Research Global Investors raised its position in shares of UnitedHealth Group by 32.1% in the 4th quarter. Capital Research Global Investors now owns 29,851,016 shares of the healthcare conglomerate’s stock worth $8,775,602,000 after purchasing an additional 7,261,158 shares during the last quarter. Capital International Investors raised its position in shares of UnitedHealth Group by 4.4% in the 4th quarter. Capital International Investors now owns 25,843,701 shares of the healthcare conglomerate’s stock worth $7,597,531,000 after purchasing an additional 1,082,141 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of UnitedHealth Group by 3.7% in the 4th quarter. Geode Capital Management LLC now owns 13,371,451 shares of the healthcare conglomerate’s stock worth $3,922,552,000 after purchasing an additional 471,331 shares during the last quarter. 87.10% of the stock is owned by institutional investors and hedge funds.
Several research firms have recently issued reports on UNH. Stephens lifted their price target on UnitedHealth Group from $300.00 to $310.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 15th. Citigroup lowered their price target on UnitedHealth Group from $346.00 to $339.00 and set a “buy” rating for the company in a research report on Friday, April 24th. Deutsche Bank lowered their price target on UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating for the company in a research report on Thursday, April 16th. Cowen lifted their price target on UnitedHealth Group from $320.00 to $340.00 and gave the stock an “outperform” rating in a research report on Thursday, April 16th. Finally, SunTrust Banks lifted their price objective on UnitedHealth Group from $340.00 to $360.00 and gave the stock a “buy” rating in a report on Thursday. Four research analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $319.68.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.63 by $0.09. The business had revenue of $64.40 billion during the quarter, compared to the consensus estimate of $64.25 billion. UnitedHealth Group had a return on equity of 24.86% and a net margin of 5.59%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company posted $3.73 EPS. Sell-side analysts anticipate that UnitedHealth Group Inc will post 16.24 earnings per share for the current year.
In related news, Director Stephen J. Hemsley sold 45,637 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the completion of the transaction, the director now directly owns 1,013,122 shares in the company, valued at approximately $292,903,701.42. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $212.00, for a total value of $1,060,000.00. Following the transaction, the director now owns 158,598 shares of the company’s stock, valued at $33,622,776. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 65,637 shares of company stock valued at $17,723,013. 0.80% of the stock is currently owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: How a Put Option Works
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.